Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms

Abstract

Our patients' results are generally compatible with the literature findings, except for the relatively high survival rate in PMF patients. Hydroxyurea was the most commonly used cytoreductive therapy. Our study reflects the demographic features, patient characteristics, treatments, and survival rates of Turkish CMPN patients.